Castle Biosciences CFO Frank Stokes named Houston Business Journal honoree

Castle Biosciences, Inc. (Nasdaq: CSTL) announced that its chief financial officer, Frank Stokes, has been named a 2026 CFO Awards honoree by the Houston Business Journal.

Stokes is one of 22 chief financial officers from the Greater Houston area selected for the recognition. Honorees will be celebrated at an awards event on July 30 and featured in the July 31 print and digital editions of the Houston Business Journal.

Stokes has served as Castle Biosciences' CFO since December 2017. According to a statement from president and CEO Derek Maetzold, Stokes helped lead the company through its Nasdaq initial public offering in 2019 and supported its growth through multiple acquisitions.

Stokes has twice been named a Top 25 CFO of Houston by TOP CFOs, most recently in 2024.

You May Also Be Interested In

• Castle Biosciences gains dual listing on Nasdaq Texas
• Merit Medical names new EVP of global operations as COO prepares to exit
• Longeveron names Nirav Jhaveri as CFO